Radcliffe Capital Management L.P. Has $2.37 Million Holdings in Oaktree Acquisition Corp. III Life Sciences $OACC

Radcliffe Capital Management L.P. increased its position in shares of Oaktree Acquisition Corp. III Life Sciences (NASDAQ:OACC) by 175.5% in the 3rd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 225,662 shares of the company’s stock after purchasing an additional 143,749 shares during the quarter. Radcliffe Capital Management L.P. owned 1.01% of Oaktree Acquisition Corp. III Life Sciences worth $2,372,000 at the end of the most recent reporting period.

A number of other large investors have also recently bought and sold shares of OACC. Goldman Sachs Group Inc. bought a new position in Oaktree Acquisition Corp. III Life Sciences in the 1st quarter valued at about $5,417,000. Moore Capital Management LP acquired a new position in shares of Oaktree Acquisition Corp. III Life Sciences in the 2nd quarter valued at approximately $5,502,000. Alberta Investment Management Corp bought a new stake in shares of Oaktree Acquisition Corp. III Life Sciences during the 2nd quarter worth approximately $5,240,000. Millennium Management LLC bought a new stake in shares of Oaktree Acquisition Corp. III Life Sciences during the 1st quarter worth approximately $4,848,000. Finally, Lighthouse Investment Partners LLC boosted its position in shares of Oaktree Acquisition Corp. III Life Sciences by 88.9% during the 2nd quarter. Lighthouse Investment Partners LLC now owns 850,000 shares of the company’s stock worth $8,882,000 after acquiring an additional 400,000 shares in the last quarter.

Oaktree Acquisition Corp. III Life Sciences Price Performance

Shares of NASDAQ:OACC opened at $10.63 on Friday. The company’s 50 day simple moving average is $10.64 and its 200 day simple moving average is $10.59. Oaktree Acquisition Corp. III Life Sciences has a 1 year low of $10.04 and a 1 year high of $10.85.

Oaktree Acquisition Corp. III Life Sciences Profile

Oaktree Acquisition Corp. III Life Sciences (NASDAQ: OACC) is a special purpose acquisition company (“SPAC”) formed to pursue merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combinations with one or more businesses in the life sciences sector. Incorporated as a Cayman Islands exempted company, OACC is sponsored by Oaktree Capital Management, a global alternative investment firm with a longstanding track record in credit strategies and private equity.